# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056971
Filing Date
2024-05-09
Accepted
2024-05-09 16:12:29
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tyra-20240331.htm iXBRL | 10-Q | 1295629
2 | EX-10.3 | tyra-ex10_3.htm | EX-10.3 | 39467
3 | EX-31.1 | tyra-ex31_1.htm | EX-31.1 | 15887
4 | EX-31.2 | tyra-ex31_2.htm | EX-31.2 | 16066
5 | EX-32.1 | tyra-ex32_1.htm | EX-32.1 | 8738
6 | EX-32.2 | tyra-ex32_2.htm | EX-32.2 | 8701
| Complete submission text file | 0000950170-24-056971.txt |  | 6490212

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tyra-20240331.xsd | EX-101.SCH | 1012310
65 | EXTRACTED XBRL INSTANCE DOCUMENT | tyra-20240331_htm.xml | XML | 1192700

Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 24930745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)